Yokohama, Japan · Founded 2019 · Privately Held (backing)
Operator of a biopharmaceutical company intended to develop therapeutic monoclonal antibody drugs for humans and animals. MabGenesis is based in Yokohama, Japan and was founded in 2019. Its last reported valuation was $18.6 million in Dec 2024. It has raised $8.8 million.
Last reported valuation
$18.6M
Oct 2026
Priced at
—
Total raised
$8.8M
Last round
—
Team — not yet on record
No current team members for MabGenesis are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of MabGenesis with a free account
·Watch MabGenesis: the Monday email on marks, rounds and moves
